ISC 2026 Session Proposal Instructions Session Type: ISC Bench to Bedside
Session Title: Hard to Crack: Comprehensive Strategies For Diagnosing and Treating Acute Large Vessel Occlusion due to Intracranial Atherosclerotic Disease
Summary (the audience will see this if proposal is accepted) Unraveling the Enigma of ICAD-LVO: A Frontier in acute stroke management large vessel occlusion due to intracranial atherosclerotic disease (ICAD-LVO) poses a significant challenge in acute stroke care, accounting for 10-30% of LVO cases. This advanced session explores the most recent diagnostic and treatment strategies, addressing critical unmet needs and pushing the boundaries of ICAD-LVO management. Groundbreaking Insights Await Immerse yourself in a comprehensive exploration of: Advanced Imaging Revolution: Discover how perfusion imaging, AI-assisted analysis, intravascular ultrasound, and optical coherence tomography are reshaping early ICAD-LVO identification. Pioneering Endovascular Approaches: Uncover the efficacy of novel first-line thrombectomy techniques, including contact aspiration, stent retrievers, and combined approaches. Conquering Re-occlusion: This session will explore strategies to combat the daunting 50% re-occlusion rate in ICAD-LVO patients post-revascularization. It will also delve into the intriguing connection between RNF213 gene polymorphism and re-occlusion risk in non-Asian populations. Emerging Rescue Therapies: This session will evaluate the potential of angioplasty, stenting, and stent angioplasty as game-changing interventions. Mastering Differential Diagnosis: Participants will learn to distinguish ICAD-LVO from its elusive mimics, including vasospasm and rare vasculopathies, to guide precise interventions and prevent complications. Bridging Today's Practice with Tomorrow's Innovations This session is a gateway to the future of ICAD-LVO care. By addressing these pressing unmet needs, we aim to revolutionize outcomes for this challenging patient subset. Delegates are encouraged to participate in order to contribute to the development of breakthroughs in the treatment of ICAD-LVO. Delegates will have the opportunity to acquire knowledge that could transform their practice and the lives of their patients. Those interested in participating are encouraged to do so to be part of the vanguard in ICAD-LVO management.

Jinkwon Kim

Yonsei University College of Medicine

Appearances